Acute Myeloid Leukemia (AML) Treatment Market Size

Acute Myeloid Leukemia Market size was valued at USD 3.41 billion in 2024 and is likely to cross USD 12.63 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of acute myeloid leukemia is assessed at USD 3.7 billion.

The number of acute myeloid leukemia patients is rising owing to the aging population across the globe. Like many other malignancies, acute myeloid leukemia (AML) is a hematological neoplasm that typically affects the elderly, with a median age of presentation of 67 years.

According to the World Health Organization (WHO), the number of individuals 60 years of age and over will double (to 2.1 billion) worldwide by 2050.